Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 148,932 | 133,010 | 127,785 | 111,585 | 99,414 |
| Cost of Goods | 28,264 | 25,537 | 23,421 | 23,018 | 22,780 |
| Gross Profit | 120,668 | 107,473 | 104,364 | 88,567 | 76,634 |
| Operating Expenses | 125,499 | 105,407 | 109,774 | 103,768 | 101,636 |
| Operating Income | -4,567 | 2,603 | -4,989 | -15,183 | -24,222 |
| Interest Expense | 3,598 | 3,606 | 3,589 | 3,596 | 3,579 |
| Other Income | 3,202 | 3,646 | 3,119 | 5,131 | 3,435 |
| Pre-tax Income | -4,963 | 2,643 | -5,459 | -13,648 | -24,366 |
| Income Tax | 767 | -262 | 402 | 1,029 | -576 |
| Net Income Continuous | -5,730 | 2,905 | -5,861 | -14,677 | -23,790 |
| Net Income | $-5,730 | $2,905 | $-5,861 | $-14,677 | $-23,790 |
| EPS Basic Total Ops | -0.11 | 0.06 | -0.12 | -0.30 | -0.49 |
| EPS Basic Continuous Ops | -0.10 | 0.06 | -0.12 | -0.30 | -0.49 |
| EPS Diluted Total Ops | -0.10 | 0.05 | -0.12 | -0.30 | -0.49 |
| EPS Diluted Continuous Ops | -0.10 | 0.05 | -0.12 | -0.30 | -0.49 |
| EPS Diluted Before Non-Recurring Items | -0.11 | 0.05 | -0.12 | -0.30 | -0.49 |
| EBITDA(a) | $1,943 | $9,108 | $1,494 | $-8,698 | $-17,750 |